Literature DB >> 15519196

Vasomotor dysfunction after cardiac surgery.

Marc Ruel1, Tanveer A Khan, Pierre Voisine, Cesario Bianchi, Frank W Sellke.   

Abstract

Cardiopulmonary bypass and cardioplegic arrest, which allow for support of the circulation and stabilization of the heart during cardiac procedures, are still used for the vast majority of cardiac operations worldwide. However, in addition to a well-recognized systemic inflammatory response, cardiopulmonary bypass and cardioplegic arrest elicit complex, multifactorial vasomotor disturbances that vary according to the affected organ bed, with reduced vascular resistances in the skeletal muscle and peripheral circulation, and increased propensity to spasm in the cardiac, pulmonary, mesenteric and cerebral vascular beds. This article outlines the nature, mechanistic basis, and clinical correlates of the vasomotor alterations encountered in patients undergoing cardiac surgery using cardiopulmonary bypass and cardioplegic arrest.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15519196     DOI: 10.1016/j.ejcts.2004.07.040

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  39 in total

1.  Decreased contractile response to endothelin-1 of peripheral microvasculature from diabetic patients.

Authors:  Jun Feng; Yuhong Liu; Kamal R Khabbaz; Robert Hagberg; Michael P Robich; Richard T Clements; Cesario Bianchi; Frank W Sellke
Journal:  Surgery       Date:  2010-08-21       Impact factor: 3.982

2.  Mast cell activation and arterial hypotension during proximal aortic repair requiring hypothermic circulatory arrest.

Authors:  Miklos D Kertai; Sreekanth Cheruku; Wenjing Qi; Yi-Ju Li; G Chad Hughes; Joseph P Mathew; Jörn A Karhausen
Journal:  J Thorac Cardiovasc Surg       Date:  2016-09-14       Impact factor: 5.209

3.  Local epicardial inotropic drug delivery allows targeted pharmacologic intervention with preservation of myocardial loading conditions.

Authors:  Mark A Lovich; Abraham E Wei; Mikhail Y Maslov; Peter I Wu; Elazer R Edelman
Journal:  J Pharm Sci       Date:  2011-06-30       Impact factor: 3.534

4.  Effects of neuropeptide Y on the microvasculature of human skeletal muscle.

Authors:  Benjamin Mirman; Ian Ikeda; Zhiqi Zhang; Yuhong Liu; Lucy Yu; Afshin Ehsan; Jun Feng; Frank Sellke
Journal:  Surgery       Date:  2020-05-31       Impact factor: 3.982

5.  Decreased coronary microvascular reactivity after cardioplegic arrest in patients with uncontrolled diabetes mellitus.

Authors:  Jun Feng; Louis M Chu; Nikola Dobrilovic; Yuhong Liu; Arun K Singh; Frank W Sellke
Journal:  Surgery       Date:  2012-08       Impact factor: 3.982

6.  Diabetes and Cardioplegia.

Authors:  Brittany A Potz; Laura A Scrimgeour; Jun Feng; Frank W Sellke
Journal:  J Nat Sci       Date:  2017-06

7.  Decreased contractile response of peripheral arterioles to serotonin after CPB in patients with diabetes.

Authors:  Sharif A Sabe; Jun Feng; Yuhong Liu; Laura A Scrimgeour; Afshin Ehsan; Frank W Sellke
Journal:  Surgery       Date:  2018-08       Impact factor: 3.982

8.  The roles of methylenetetrahydrofolate reductase 677C>T and 1298A>C polymorphisms in moyamoya disease patients.

Authors:  Young Seok Park; Young Joo Jeon; Hyun Seok Kim; In Bo Han; Joong-Uhn Choi; Dong-Seok Kim; Nam Keun Kim
Journal:  Childs Nerv Syst       Date:  2014-08-07       Impact factor: 1.475

9.  Effect of arterial oxygen tension during reperfusion on myocardial recovery in patients undergoing valvular heart surgery.

Authors:  Jeong-Soo Lee; Jong-Chan Kim; Joo-Young Chung; Seong-Wook Hong; Kil-Hwan Choi; Young-Lan Kwak
Journal:  Korean J Anesthesiol       Date:  2010-02-28

10.  Large conductance calcium-activated potassium channels contribute to the reduced myogenic tone of peripheral microvasculature after cardiopulmonary bypass.

Authors:  Jun Feng; Yuhong Liu; Kamal R Khabbaz; Neel R Sodha; Robert M Osipov; Robert Hagberg; Seth L Alper; Frank W Sellke
Journal:  J Surg Res       Date:  2009-05-03       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.